Skip to main content

Alpine Immune Sciences, Inc.

ALPNDelisted May 20, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001626199

Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.

Holders of 5% or more of ALPN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Alpine Immune Sciences, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Alpine Immune Sciences, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Alpine Immune Sciences, Inc., newest first.

No Schedule 13D or 13G filings on Alpine Immune Sciences, Inc. are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Alpine Immune Sciences, Inc. shares.

No Form 144 notices for Alpine Immune Sciences, Inc. are on file.